Jane H. Hollingsworth's most recent trade in CervoMed Inc was a trade of 8,100 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CervoMed Inc | Jane H. Hollingsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 8,100 | 8,100 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 5,750 | 5,750 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 183 | 183 | - | - | Restricted Stock Unit | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 183 | 1,299 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 May 2023 | 68 | 1,231 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 183 | 366 | - | - | Restricted Stock Unit | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 183 | 1,184 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2023 | 68 | 1,116 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2022 | 183 | 1,069 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2022 | 183 | 549 | - | - | Restricted Stock Unit | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Nov 2022 | 68 | 1,001 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 183 | 838 (0%) | 0% | - | Common Stock | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 183 | 915 | - | - | Restricted Stock Unit | |
| CervoMed Inc | Jane H. Hollingsworth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 May 2022 | 67 | 771 (0%) | 0% | - | Common Stock |